socalTECH

JULY 10, 2020

Monrovia, California-based biopharmaceuticals developer Xencor says it has linked with another biotechnology company, Atreca , to research, develop and commercialize T cell engaging bispecific antibodies as potential therapeutics in oncology. READ MORE>>.

Monrovia 113

Monrovia Research Develop Development 113

socalTECH

FEBRUARY 5, 2020

Monrovia-based Xencor says it has licensed the rights to its XmAB7195 monoclonal antibody, to Aimmune Therapeutics , a company that it working on treatments of food allergies. Xencor also said the deal is worth up to another $385M based on clinical development, regulatory, and commercialization milestones. READ MORE>>.

Monrovia 113

Monrovia Equity Develop Development 113

socalTECH

FEBRUARY 11, 2020

Monrovia, California-based AeroVironment , which develops unmanned aerial vehicles, said late Monday that it has received a $8.5M military sales contract from an un-named, U.S. According to AeroVironment, the $8,584,734 firm-fixed-price U.S.

Outsource Development 113

Outsource Development Monrovia Training Sales 113

socalTECH

MARCH 26, 2020

Monrovia, California-based Xencor , a biopharmaceutical company which develops engineered monoclonal antibodies for the treatment of cancer and autoimmune disease, says it is extending a license for its technology to Vir Biotechnology , in use in developing antibodies to treat COVID-19, the disease cased by the novel coronavirus SARS-CoV-2.

Technology 124

Technology Monrovia Develop Development 124

socalTECH

OCTOBER 8, 2018

Monrovia, California-based Aerovironment , a major developer of unmanned aerial vehicles (UAVs) and drones for the military, said it has inked a deal with General Dynamic Land Systems (GD), to integrate the company's unmanned aircraft and tactical missle systems with armored combat vehicles. READ MORE>>.

Monrovia 147

Monrovia Help Technology Develop 147

socalTECH

DECEMBER 18, 2019

Monrovia-based biopharmaceuticals developer Xencor announced this morning that it has named Allen Yang, M.D., Yang was most recently Senior Vice President, Head of Clinical Development, and acting Chief Medical Officer at Jazz Pharmaceuticals. as its new Senior Vice President and Chief Medical Officer.

Monrovia 100

Monrovia Southern California Research Develop 100

socalTECH

JUNE 5, 2018

Monrovia, California-based Aerovironment , the developer of unmanned aircraft systems, has sold its other business--focused on electric vehicle charging and test systems--to a German company, Webasto Group. According to the two companies, Aerovironment sold its Efficient Energy Systems (EES) business segment to Webasto for $35M.

Monrovia 153

Monrovia Company Companies Help 153

socalTECH

DECEMBER 20, 2019

Monrovia-based biopharmaceuticals developer Xencor announced on Friday morning that it has naed a new member of its board of directors. According to the company, it has appointed Dagmar Rosa-Bjorkeson, the former Executive Vice President and Chief Strategy and Development Officer at Mallinckrodt Pharmaceuticals to its board.

Monrovia 100

Monrovia Develop Development Company 100

socalTECH

OCTOBER 8, 2020

HAPSMobile , the developer of a solar-power, unmanned aircraft system which is part owned by Monrovia, California-based Aerovironment , has seen a successful stratospheric test flight of its solar powered unmanned glider, the company said late Wednesday. Aerovironment is the developer of the Sunglider unmanned aircraft.

Monrovia 113

Monrovia Google Design Develop 113

socalTECH

FEBRUARY 5, 2019

Monrovia-based biopharmaceuticals technology developer Xencor has received $120M in an upfront payment from Genentech this morning--and up to another $180M in development milestones--as part of a new deal to commercialize an immune activating cytokine based on Xencor's technology.

Monrovia 113

Monrovia Activity Research Invest 113

socalTECH

OCTOBER 5, 2018

Monrovia, California-based Aerovironment , which develops unmanned aerial vehicles (UAVs) for the military market, reports that it has received a $13M contract from the United States Air Force. According to AeroVironment, the new contract award covers support of Latin America and Caribbean nations with its RQ-11B Raven drone.

Outsource Development 113

Outsource Development Monrovia Report Marketing 113

socalTECH

DECEMBER 19, 2017

Monrovia-based Xencor , which develops biopharmaceuticals using engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, said today that it has named Richard Ranieri to its Board of Directors. He also has served at Denderon Corporation, Sepracore, Neurocrine Biosciences, Inc.,

Monrovia 113

Monrovia Resource Develop Development 113

socalTECH

JANUARY 10, 2019

Monrovia, California-based VivoAquatics , a provider of water management services for hotels, resorts, and waterparks, has raised $8M in a funding round, according to a regulatory filing by the company this week. Details of the funding had not yet been announced by the company. READ MORE>>.

Monrovia 113

Monrovia Equity Funding Services 113

socalTECH

MARCH 2, 2018

Monrovia, California-based Aerovironment , which develops unmanned aerial vehicles (UAVs) for the military and other markets, reported a win this week with the Royal Canadian Navy. Financial details of the contract were not announced.

Monrovia 113

Monrovia Outsource Development Report Marketing 113

socalTECH

MARCH 9, 2017

Monrovia, California-based AeroVironment has been selected by auto manufacturer Volvo Cars , to develop a custom electric vehicle (EV) charging station, the company announced on Thursday. Financial details of the deal were not announced.

Monrovia 124

Monrovia Customer Custom Develop 124

socalTECH

JULY 5, 2018

Monrovia, California-based unmanned aerial vehicle maker Aerovironment said this week that it is collaborating with the NASA Jet Propulsion Laboratory , to develop a drone which can fly on Mars. According to Aerovironment, the Mars Helicopter is now in production at JPL, with plans to fly the drone on Mars in less than three years.

Monrovia 100

Monrovia Product Develop Development 100

socalTECH

APRIL 17, 2017

Monrovia-based biopharmaceuticals developer Xencor announced this morning that it has named Kevin Gorman, ph.D., to its board of directors. Gorman is the CEO of Neurocrine Biosciences, where he has been since 1993; he previously was an investor at Avalon Medical Partners, L.P. Gorman replaces director Robert Baltera, Jr.,

Avalon 113

Avalon Monrovia Develop Development 113

socalTECH

MARCH 7, 2018

Monrovia-based unmanned aircraft systems developer AeroVironment reports that it has received a big, $44.5M contract for its Puma II AE platform, with an un-nnamed, major country in the Middle East. According to Aerovironment, the deal is the largest-ever international contract for the company.

Outsource Development 113

Outsource Development Monrovia Platform Report 113

socalTECH

JUNE 8, 2017

Monrovia, California-based biopharmaceuticals developer Xencor announced today that it has named Raphael Clynes, M.D., as its new Vice President of Translational Biology.

Monrovia 113

Monrovia Study Develop Development 113

socalTECH

DECEMBER 1, 2016

Monrovia-based biotechnology developer Xencor has launched a public offering of its common stock, with the aim of raising approximately $110M in funding, the company said on Wednesday. The publicly traded biotechnology developer--which trades on the NASDAQ as XNCR--said it has priced the offering at $24.000 per share.

Monrovia 100

Monrovia Pricing Capital Invest 100

socalTECH

OCTOBER 11, 2013

Monrovia, California-based biopharmaceuticals developer Xencor has filed for an IPO, saying in a filing this morning that it looking to raise up to $69.0M Xencor, which is led by Bassil Dahiyat, develops engineered monoclonal antibodies, which are being used to treat autoimmune and allergic diseases, cancer and other conditions.

Monrovia 185

Monrovia Acquisition Marketing Develop 185

socalTECH

APRIL 26, 2013

Monrovia, California-based Parasoft , which develops software testing tools, said today that it has linked with Electric Cloud , a provider of cloud-based software testing services, to integrate their technologies. parasoft electric cloud saas paas testing software development' READ MORE>>.

Software 153

Software Monrovia SaaS Tool 153

socalTECH

DECEMBER 3, 2013

Monrovia-based biopharmaceuticals developer Xencor said this morning that it has priced its IPO, at $5.50 per share, and will start trading today on the NASDAQ Global Market as XNCR. Xencor sold 12,730,000 shares of its common stock in the IPO. Xencor was venture backed by MedImmune Ventures, HealthCare Ventures, and others.

Pricing 138

Pricing Monrovia Acquisition Marketing 138

socalTECH

APRIL 10, 2014

Monrovia-based biopharmaceuticals developer Xencor reports this morning that it has received a milestone payment from Merck, for the initiation of a Phase 1 clinical trail which uses its antibody engineering technology. Size of that milestone payment was not announced. READ MORE>>.

Monrovia 138

Monrovia Report Technology Help 138

socalTECH

JULY 31, 2015

Monrovia-based biopharmaceuticals developer Xencor announced this morning that it has appointed Yujiro S. Hata to its board of directors. Hata is currently the Chief Operating Officer at FLX Bio, and he previously was Chief Operating Officer at Flexuss Biosciences.

Monrovia 100

Monrovia Develop Development Company 100

socalTECH

OCTOBER 3, 2013

Monrovia, California-based Parasoft , which develops software testing tools, has launched a new product aimed at the automated, continuous testing market. The company said it has released a new API Testing Solution, which can be used as part of continuous integration and release efforts. READ MORE>>.

Monrovia 147

Monrovia Software Software Development Tool 147

socalTECH

NOVEMBER 14, 2013

Monrovia, California-based Xencor has set the initial offering price for its IPO, saying in a filing Thursday morning that it will offer up 10,700,000 shares of its common stock at $7.00 The company develops biopharmaceuticals technology. The company plans to trade on the NASDAQ Global Market as XNCR. and $16.00 and $16.00 READ MORE>>.

Pricing 157

Pricing Monrovia Acquisition Marketing 157

socalTECH

DECEMBER 8, 2016

Monrovia, California-based unmanned aerial vehicle maker AeroVironment is ramping up its efforts in developing more commercial applications for its drones, saying it has launched a new effort with California State University, Fresno on identifying water stress in almond production using its UAVs.

Study 100

Study Monrovia Help Product 100

socalTECH

SEPTEMBER 16, 2015

Thousand Oaks-based Amgen , and Monrovia, California-based Xencor said this morning they are in a strategic collaboration worth as much as $1.7 billion to Xencor, to develop and commercialize cancer immunotherapy and inflammation drugs. The two said that Amgen will pay Xencor $45M upfront, with the potential of up to $1.7

Thousand Oaks 100

Thousand Oaks Monrovia Platform Sales 100

socalTECH

DECEMBER 3, 2012

Monrovia, California-based Aerovironment , the developer of unmanned aircraft systems, said this morning that it is making an investment in a Swedish developer of vertical takeoff and landing (VTOL) systems. The move comes as part of an effort to provide VTOL unmanned aircraft systems to Aerovironment's customers.

Invest 153

Invest Monrovia Customer Custom 153

socalTECH

DECEMBER 6, 2016

Monrovia, California-based AeroVironment , which develops both unmanned aerial vehicles and electric vehicle charging stations, has scored a win with General Motors. The company said on Tuesday afternoon that its EVSE-RS charging station has been selected as the official home charging station for GM's new 2017 Chevrolet Bolt EV.

Monrovia 100

Monrovia Develop Development Company 100

socalTECH

AUGUST 8, 2013

Monrovia, California-based AeroVironment , the developer of unmanned aircraft and electric charging devices, said Wednesday that it has named Douglas E. Scott as its new Seniro Vice President and General Counsel. Scott joins AeroVironment from SAIC, where he led the firm''s legal department.

Monrovia 138

Monrovia Develop Development 138

socalTECH

NOVEMBER 4, 2013

Monrovia, California-based Xencor , the biopharmaceuticals technology developer headed by Bassil Dahiyat, has set its IPO pricing range, saying today in a regulatory filing that it is expecting to price its IPO at between $14.00 and $16.00 The company is looking to trade as XNCR on the NASDAQ Global Market.

Pricing 138

Pricing Monrovia Acquisition Marketing 138

socalTECH

NOVEMBER 18, 2013

Monrovia-based Xencor , the developer of biopharmaceutical technology headed by Bassill Dahiyat, delayed its IPO Friday, citing poor market conditions for the offering. The company had hoped to IPO on the NASDAQ Global Market. The company is backed by MedImmune Ventures, HealthCare Ventures, and others.

Monrovia 147

Monrovia Southern California Social Network Acquisition 147

socalTECH

OCTOBER 8, 2014

Monrovia, California-based unmanned aircraft maker AeroVironment reported today that it has scored another contract from the Defense Advanced Research Projects Agency (DARPA).

Outsource Development 138

Outsource Development Monrovia Design Research 138

socalTECH

NOVEMBER 8, 2013

Monrovia-based unmanned aircraft maker Aerovironment said this week that it has entered into a $2.3M According to Aerovironment, it will help to develop a medium altitude, long-endurance unammned aircraft system designed to operate from small ships, and to provide persistent intelligence, surveillance, and reconnaissance (ISR) capabilities.

Outsource Development 138

Outsource Development Monrovia Research Design 138

socalTECH

AUGUST 28, 2013

Monrovia-based CODA Energy , the battery developing spinout from CODA Automotive, said this morning that it has scored an energy storage win in the San Francisco Bay Area. CODA is developing battery technology for use both in electric cars (EVs) and in energy storage applications. Financial details of the win were not announced.

Monrovia 153

Monrovia Technology Develop Development 153